Life sciences sector is heartbeat of Michigan innovationZiad
When you think of medical innovation, you may think of San Diego, Boston or the San Francisco Bay area. But entrepreneurial activity in medical innovation has been flourishing across Michigan and top talent, investors and leading life science corporations across the world have taken notice.
For instance, this year an Ann Arbor-based biotech startup, RetroSense Therapeutics, was acquired by leading global pharmaceutical company Allergan plc for $60 million for its novel gene therapy approach to vision restoration. RetroSense, a tenant of the Michigan Economic Development Corp.-backed Michigan Life Sciences and Innovation Center, benefited early on by working with MEDC SmartZone Ann Arbor Spark and was the recipient of more than $450,000 in direct MEDC early stage investment. Read more >>